research articl analyz policymak tuberculosi control nigeria nura m. r. ahmad ,1,2 cristina montaola-sal ,2,3 clara prat ,1 mustapha musa,4 daniel lpez ,1 josep casanovas-garcia 1,2 1universitat politecnica catalunya, barcelona, spain 2barcelona supercomput center (bsc), barcelona, spain 3iq barcelona, ramon llull university, barcelona, spain 4gomb state primari health care develop agency, gombe, nigeria correspond address cristina montanola-sales; receiv 18 2018; revis 25 septemb 2018; accept 11 octob 2018; publish 7 novemb 2018 guest editor: bernardo a. furtado copyright 2018 nura m. r. ahmad et al. open access articl distribut creativ common attribut license, permit unrestrict use, distribution, reproduct medium, provid origin work properli cited. today, tuberculosi (tb) major threat humankind, caus death infecti diseas worldwide. tb communic chronic diseas year affect 10 million peopl kill 2 million peopl world. main kei factor fuel diseas progress urban popul poverty-rel socioeconom factors.moreover, lack effect tool tb diagnosis, prevention, treatment decis contribut lack effect model predict tb spread. nigeria, rapid urban unpreced popul growth caus tb endemic. paper propos mathemat model evalu tb burden nigeria data obtain local tb control program community. research aim point effect strategi effect reduc tb burden death tb countri differ levels.th studi show effort orient activ case find increas treatment effect only. reveal persist diseas relat larg number latent infect individu quantifi live save increas notif rate activ case find strategy.w conclud undiagnosi bottleneck need overcom addit incorporation, improvement, and/or strengthen treatment manag essenti tb control measur nigeria. 1. introduct tuberculosi (tb) challeng infecti diseas humankind faces. estim 200 year tb kill billion (1.000.000.000) peopl [1]. cur- rently, tb main worldwid caus death infecti diseas [2]. 2017, 10.4 million new tb case 1.7 million relat death worldwid [3]. silent diseas eludedmankind long time. affect peopl social statuses, tb case occur resource-limit countries. tb caus mycobacterium tuberculosi (mtb). bacillu transmit inhal infect aerosol gener activ tb patients. inhal bacilli usual lead trigger immun respons differ clinic outcomes: (1) complet clearanc pathogen, (2) latent tb infect (ltbi), (3) progress primari activ diseas [4, 5]. ltbi occur host immun respons manag initi contain mtb develop encapsul granulomas. not, bacilli remain phys- ical contain immunolog constrain encapsul granuloma lifetim host [6, 7]. process, endogen reinfect produc new infect spotlight presum undergo control dynam [4]. however, decad infect especi case immunocom- promis host (like hiv patients), control process fail host develop activ disease. average, 10% ltbi peopl develop activ tb live [8]. latent infect host reinfect times, increas load mtb bodi hindawi complex volum 2018, articl id 9253846, 13 page 2 complex increas chanc progress activ disease. accord world health organ (who), estim number 2 3 billion peopl ltbi 2015 [9], risk develop activ disease. overcrowd time contact patient kei factor tb infection. paradoxically, tb seen xix centuri disease, mainli associ poor live condit worker crowd cities. today, tb reach highest number case absolut number histori [9] precis massiv urban populations. fact especi pain nigeria, countri undergo rapid urban rapidli grow population. current growth rate 2.8% 3.5% year, estim nigeria urban popul doubl decad [10]. consequence, tb endem nigeria. control diseas coordin thenat tuberculosi leprosi control program (ntblcp), line end tb partnership initi ultim target elimin tb public health problem year 2050 (mean reach 1 case million-person population) [11]. despit current global control effort reduc tb, nigeria tb incid refus signific declin [9]. march 14th, 2017, wide circul paper announc nigeria rank 4th tb infect worldwid [12]. follow press releas ntblcp nation coordinator. statist 80% tb case nigeria undetect diseas claim million live year countri [9, 13]. studi intensifi case find need especi area higher preval tb [14 16]. instance, brewer et al. [17] indic activ case find tb homeless individu usa effect strategi lead decreas death thetb patients. moreover, studi dodd et al. [18] indic policymak need altern activ case find passiv case detect strategi period period order effect tb control. paper aim us mathemat model order evalu effect increas diagnosi rate treatment success tb dynam nigeria. assess tb policymaking: mathemat model tb transmission. mathemat model estim long-term dynam tb help assess develop strategi control it. literatur compart model complex system exten- sive [1921]. follow top-down approach, popul divid differ compart (e.g., susceptible, exposed, infected, recov case seir model) specif flux set compart- ments. dynam diseas defin ordinari nonlinear differenti equat rigor mathemat analysi [22]. differ studi abl draw import conclus tb dynam mean model method [2333]. okuongha ikhimwin [16], example, develop model classifi popul tb awar level, kei factorwhich affect case detect rate. factor contribut better adjust tb model hiv dynamics, especi sub-saharan african region [34]. hiv patient higher risk infect progress activ diseas infect non-hiv infect people. accord towho [35], nearli hiv-posit peopl activ tb die. mean mathemat models, walli [36] abl identifi individu innat resist mtb. conclud understand mechan resist lead therapeut strategi counter immun evas mtb. moreover, model walli [36] assess affin ltbi reactiv patient administ drug tnf blockers. similarly, research project moualeu-ngangu et al. [37] work model simul global tb dynamics. studi show tb spread crucial depend basic reproduct number (number new case case gener sick period, estim 10 15 [36, 38]). research cameroon role tb diagnosis, treatment, tb awar level, tradit medicin dynam tb assessed. song et al. [39] investig epi- demiolog time scale tb evalu risk infect close contact (clusters) casual contact (random). conclud risk infect depend sourc infect differ environment characteristics. lastly, guzzeta et al. [40] present differ wai model tb dynamics: (1) od model ag structur constant popul size, (2) age- structured, stochast version od model, (3) sociodemograph individual-bas model (ibm). ibm model form autonom agent interact them, includ environment, follow objectives. model fit epidemiolog data arkansas, usa. author conclud differ model techniqu advantag drawback chosen carefully. example, od model best suit evolut prevalence, incidence, mortality. hand, ibm best estim fraction reactiv case fit age-specif incid activ tb. aremani studi tb epidemic, cause, spread, suggest measur therapi control, aforement studi us mathemat model evalu actual epidem tb nigeria data obtain local tb control program community. paper propos mathemat model evalu tb burden country. aim point effect strategi effect reduc tb burden death tb nigeria. specifically, present mathemat model aim investig tb activ case find need nigeria, order help policymak sound decis implement effect tb control measur country. section 2 show developedmethodolog explain propos model. section 3 4 present discuss result obtain limit complex 3 possibl research. finally, section highlight main conclus drawn study. 2. materi method goal develop close-enough-to-r mathemati- cal model tb epidem allow investig effect demograph notif tb epidem popul nigeria, estim actual burden diseas includ death toll case fertil ratio region country. 2.1. model description. figur 1 repres model dia- gram, briefli outline. birth occur constant rate suscept class s assumpt newborn suscept tomtb. 1 , 2 , . . . , 7 , >7 repre- sent noninfecti popul infect tuberculosi clinic symptom (ltbi) year infection; i.e., individu infect recent (less year ago) assign 1 , individu whowa infect yearwould assign 2 population. ltbi compartment, >7, consist latent infect popul 7 year infection. 1 2 repres popul sick; i.e., activ diseas clinic symptom infect gener population; sick popul diagnos receiv effect chemoprophylaxis, unabl infect anyone. shown diagram, peopl 2 compart diagnos compartment, 1 compart account miss tb cases. death rate model depend diseas status; fix suscept population, ] 1 expos classes, 1 , 2 , sick individu 1 , 2 , , respectively. base dispar time scale natur death versu death tb disease, assum ] 1 2 1 . transmiss mtb tb occur follow adequ contact sick infecti individu ( 1 2 ) suscept population. assum latent infect ( ) infecti capabl transmit bacteria. us incid express ( 1 + 2 )/ indic success transmiss ofmtb nonlinear contact dynam larg popul [41]. transmiss rate repres possibl interact occur suscept popul sick infecti population, defin averag contact unit time. infect 1 assum lower (0 1), undiagnos long-term sick individu probabl reduc activ poor health conditions. newli infect individu progress directli infect class 1 stai period year, probabl develop activ diseas 1 . sick, progress 2 (at capita rate 1 ) subsequ year, probabl develop activ diseas 2 . progress latent infect compart continu yearli constant capita rate 1 . finally, latent infect patient (i1 + i2) n s i1 i2 t s 1 1 1 1 1 1 1 8 e e e e e e e e> p1 p5 p3 p4 p6 p7 p8 p2 k3 k4 k2 k1 k1 k1 k1 k1 k1 k1 (1 ) t figur 1:themodel: compart model tuberculosi transmis- sion nigeria. model show dynam flow tuberculosi (tb) includ suscept popul ; latent infect pop- ulat discern base time infected; 1 stand peopl latent infect period year, 2 stand peopl infect 2 years, etc.; >7 stand peopl infect 7 years; type nondiagnos sick popul considered, 1 2 , sick treatment shown . birth occur constant rate . transmiss mtb depend ( 1 + 2 )/ probabl lead activ tb given = 2++, year infection. 1 indic success infect compart next. fraction sick, , detect notified; 2 relat diagnosi time delai start treatment indic fraction relaps sick treatment. recoveri rate given 3 4 repres fraction infect popul get rid diseas spontaneously. account cours death, , ] , 2 , , death activ tb, 1 . seven year infect remain compart >7 long period time, probabl sick ( 8 ) low later integr suscept societi constant capita rate 4 . probabl develop activ diseas decreas latent infect compartment, , assum autonom decreas quadrat function, given = 2 + + , year infection. sum ( ) repres 1013% latent infect popul sick seven year more, 1 1 + 2 2 5-6% latent infect popul sick year infection. defin fraction sick infecti popula- tion notifi receiv effect chemopro- phylaxis, 2 rate effect capita notification, 3 capita rate success therapi completion. assum start treatment remov individu infecti class 2 place . assum individu receiv chemoprophylaxi abandon therapy, show relaps capita rate . 4 complex 2.1.1. model formulation. nonlinear differenti equat model dynam individu popul settings. set () = () + 1 () + 2 () + 3 () + 4 () + 5 () + 6 () + 7 () + >7 () + 1 () + 2 () + () suppress time dependence, , variable,() repres total popul size time . model equat = + 4>7 + 3 ( ( 1 + 2 ) + ) , (1) 1 = ( ( 1 + 2 ) ) (]1 + 1) 1 + 11, (2) 2 = 11 (]1 + 1) 2 + 22, (3) 3 = 12 (]1 + 1) 3 + 33, (4) 4 = 13 (]1 + 1) 4 + 44, (5) 5 = 14 (]1 + 1) 5 + 55, (6) 6 = 15 (]1 + 1) 6 + 66, (7) 7 = 16 (]1 + 1) 7 + 77, (8) >7 = 17 (]1 + 1) >7 + 8>7, (9) 1 = (1 ) () + (1 ) 8>7 11, = 1, 2, 3 . . . , 7. (10) 2 = () + 8>7 + (2 + 2) 2, = 1, 2, 3 . . . , 7. (11) = 22 ( + 3 + ) . (12) equat (1) describ rate chang suscept popul . gain popul constant birth rate . loss popul occur result infect mtb transmiss rate ( 1 + 2 )/ constant death rate s. equat (2) (9) repres rate chang latent infect popul time. rate chang 1 increas result mtb infect result latent infect rate ( 1 + 2 )/ decreas develop activ tb rate 1 1 , natur death ] 1 , movement second year latent infect class rate 1 1 . 2 (), 3 (), . . . , >7 () increas success movement latent infect individu class decreas progress movement infect class, natur death ] 1 , develop activ tb rate latent infect class. fraction (1 ) mtb infect progress activ tb undetect decreas death tb caus rate 1 , detect fraction increas relaps rate decreas diagnosi rate 2 2 death rate 2 . rate chang sick individu treatment increas rate 2 2 reduc rate , recoveri rate 3 , natur death rate . 2.1.2. model calibr validation. order deter- effect paramet dynam tb innigeria, (1) (12) integr rungekutta method order 4, matlab softwar (ode45). start fit ourmodel 20002010 preval data onnigeria offici report nigerian epidemiolog fact sheet [42]. reason period chosen reliabl avail data fact paramet approxim consid constant period, applic period longer. squar curv fit matlab, specifi lower upper bound specif paramet estimated. recruit rate suscept chosen calcul popul countri remain constant simulation. treatment efficaci (1 ) consid 80% probabl relaps taken 20%. paramet valu gave best fit given tabl 1 obtain 2 = 0.9992. initi condit chosen accord avail- abl data possibl (i.e., total population, esti- mate global ltbi population, popul sick compartments, ratio 1 / 2 ). distribut ltbi time-since-infect compart fit process. final obtain initi condit (consid popul 100,000): ( (0) , 1 (0) , 2 (0) , 3 (0) , 4 (0) , 5 (0) , 6 (0) , 7 (0) , >7 (0) , 1 (0) , 2 (0) , (0)) = (58303, 6100, 5000, 4438, 4020, 3550, 3140, 2860, 12250, 284, 55, 0) . (13) correspond initi preval 339 notifi- cation rate 16%. figur 2 show epidemiolog data best fit model. valid previou calibration, took data wider period (19902015) confront model. keep paramet constant small chang forc infect value, initi conditions, new2 0.9706.therefore, assum calibr 20002010 period baselin subsequ virtual experiments. complex 5 tabl 1: summari descript paramet model fit nigeria data (2000-2015). paramet paramet descript valu (1) sourc birth rate s class constant na death rate s 0.012 calibr 1 death rate 1 0.146 calibr 2 death rate 2 0.146 calibr death rate 0.01 calibr ] 1 death rate ltbi 0.0108 calibr contact rate sick popul 3.54 calibr 1 movement rate ltbi popul 1 12 calibr probabl develop activ tb 2 + + deriv notif rate 0.16 [35] reduc probabl sick individu 1 0.78 calibr 3 recoveri rate 1 6 [35] 4 invers tb clearanc rate 1 120 calibr relaps rate 0.20 [35] ] 8 death rate >7 0.008 calibr 2 invers diagnosi delai time 1 3 [11] probabl compon activ tb 0.001035 calibr probabl compon activ tb -0.0152 calibr probabl compon activ tb 0.06 calibr (1 ) effect tb treatment rate 0.80 [35] epidemiolog data calibr model 2002 2004 2006 2008 20102000 time (years) 200 250 300 350 400 pr ev al en ce /1 00 ,0 00 figur 2:model simul calibr tuberculosi preval data nigeria: figur show tuberculosi preval curv model, calibr 20002010 data, compar data estim period. model preval curv obtain solv (1) (12), initi condit (13) paramet valu tabl 1.the goodness-of-fit measur (2) simul trajectori evalu 0.9992. 2.2. fact hypotheses. purpos paper, assum constant birth rate . newborn model suscept class uninfected, tb/hiv coinfect explicitli modeled.thes assumpt simplif relev current purpose, identif signific damag caus poor case detect tb control program. modifi subsequ studi order account effect chang birth rate time evalu signific tb/hiv coinfection. propos us model explor dif- ferent situat nigeria virtual experi platform. situat evalu select start work wide hypotheses, final confirm requir research includ on- field project incorpor expert involv disciplines. start hypothes following: (1) tb preval remain major health challeng nigeria poor case detect (2) increas effect treatment necessarili caus signific decreas preval tb countri activ case find implemented. words, increas notif rate necessari decreas tb transmiss nigeria (3) persist nondecreas dynam tb nigeria relat larg number latent infect individu (4) poor notif rate result larg number (hundr thousands) death tb patient 3. result numer simul model allow estim import paramet associ tb nigeria. addition, abl observ quantifi effect 6 complex infect popul preval tb country. allow distinct connect notif paramet death toll sick popul (infectious) population, relationship death preval diseas country. illustr effects, divid section 3 subsections. hypothes 1 2 explain case detect effect treatment affect tb dynam nigeria; predict new tb case provid altern strategi tb control.hypothesi 3 explain relationship ltbi dynam tb prevalence. finally, mean hypothesi 4 quantifi death tb estim death toll tb decad nigeria, estim live save altern strategi proposed. 3.1. hypothes 1 2: case detect effect treat- ment. model successfulli fit data tb preval nigeria. then, compar fit tendenc predict increas notifica- tion parameter. paramet valu obtain fit model data nigeria briefli summar discuss tabl 1. shown figur 2, obtain baselin simul repres epidem tb situat nigeria successfully. valu paramet determin vital statistics: tb data ntblcp gomb state, offici tb data world health organ (who), recent literaturesment tabl 1. valu estim data literature, case paramet associ contact rate, obtain model fit epidemiolog data (2 = 0.9992). recall,whoestim 30%of theworld popu- lation infectedwith ltbi [43].however, themodel reveal 3437%(depend choic contact rate sick popul paramet calibrated) nigeria popul latent infect tb.thi popul distribut infect class rang 1 >7 , time infect popul fitted. model investig noti- ficat new tb case affect dynam tb nigeria. test hypothesi nonimprov notif observ situat nigeria partial explain preval tb countri persist declin compar others, show incid rate 400 500/100,000 (more 130 time incid rate usa) [44 46]. notif rate tb nigeria 16% [35]. therefore, initi condit new tb case calcul assign 16% new case 2 (i.e., compart gather sick popul goe hospit receiv care point), 84% assign 1 (i.e., popul remain sick life cycl death). figur 3 show fit themodel preval tb nigeria, namely, baseline, figur 3: hypothesi 1: baselin simul effect notifica- tion rate. model fit preval tuberculosi nigeria. blue star repres epidemiolog data tuberculosi prevalencewhil red line-circl repres themodel simulation. fit 16% sick popul notified. experi repeat 20% (yellow curve), 25% (green curve), 30% (black curve), 60% (magenta curve), 85% (cyan curve) notification, respectively. simul increas notif rate explored. mean preval epidemiolog data 330.64 standard deviat 6.7, mean model 330.39with standard deviat 6.6 an2 coeffici 0.9992 (tabl 2). model pretti consist epidemiolog data.themean result preval simul notif rate record tabl 2 well. result clear decreas preval tb notif new tb case increases. baselin simulation, model predict 62,000 death tb year 1990, 72,000 death year 1995, 118,000 year 2014.these result rang annual tb death estim [35]. figur 4 show predict declin preval 10 year notif rate tested. fact, simpli 10% rel increas case notif peopl activ tb reduc tb preval 15% compar current situation. predict tb death declin 15% compar baselin simul fit epidemiolog data. new simul seri design order explor effect improv effect treatment, i.e., decreas . result show 10% improv effect treatment activ tb individu produc declin 5% preval tb relat death compar baselin fitting, shown figur 5(a). complex 7 tabl 2: summari mean preval data model simulations, 2 fitting. case detect rate mean preval standard deviat refer epidemiolog data 330.64 6.7 [35] model 16%notif 330.40 6.8, 2 = 0.9992 model model 20%notif 311 na model model 25%notif 288 na model model 30%notif 266 na model model 60%notif 156 na model model 85%notif 105 na model preval 10 year 50 100 150 200 250 300 350 pr ev al en ce /1 00 ,0 00 20 30 40 50 60 70 80 9010 notif rate (%) figur 4: hypothesi 1: evolut tuberculosi preval nigeria 10 year simul differ notif rate. point curv show preval tuberculosi nigeria simul correspond notif valu x-axi 10 years. given results, effect intervent reduc- ing futur tb case relat death nigeria predict model activ case finding. final virtual experi design order ex- plore effect improv effect treatment context high case detect rate. simul series, detect rate fix 80% differ treatment success rate explored. result show that, case, improv treatment effective- ness provid signific decreas tb preval (figur 5(b)). notif rate 80%, increas effect treatment 10% lead declin preval 23% associ death 30%. case poor case detect rate, increas 10% effect treatment associ 5% decreas preval relat deaths. therefore, increas treatment effect relev combin activ case find scenario notif rate significantli high. nevertheless, grow problem multidrug-resist tb, invest treatment relev need main- tained. 3.1.1. tb predict nigeria. look current tb situat nigeria, wonder situat paramet left unchang especi term passiv case finding.w envis scenario andwith help baselin simul results, follow result presented. figur 6(a) show predict evolut tb notif rate gradual increased, figur 6(b) show effect sudden increas parameter. simul start baselin repres current situat (16% notification, red-dash line). keep notif ratewithout chang preval tb countri 350 320/100,000 40 year present day. precis present situat tb nigeria, signific chang declin tb preval past 25 year (323/100,000 1990 332/100,000 2015 [35]). increas notif rate 20% 10 year preval 300 290/100,000 people. effort increas notif further, preval remain rang period 50 years. increas notif 25% 10 year reduc preval 290 260/100,000 people, increas notif 30% bring preval 220 240/100,000.we repeat experi sudden increas notif 16% 30% seen figur 6(b) preval remain rang 270/100,000 280/100,000. success reason declin tb case nigeria achieved, case find need activ increas period time time. 30% notif rate viable, real tb preval decreas nigeria achiev notif rate 80%. strategi present figur 3 6 produc result long run term tb preval decline. however, term public health, progress decreas strategi feasibl econom resourc need alloc health authorities. contrast, increas notif rate larg percentag ambiti resourc demanding. junction, import point abl intervent soon possibl given long time requir actual chang tb prevalence. 3.2. hypothesi 3: latent infect population. known latent infect individu connect 8 complex epidemiolog data 80% treatment success rate 85% treatment success rate 90% treatment success rate 95% treatment success rate 0 50 100 150 200 250 300 350 400 pr ev al en ce /1 00 ,0 00 2005 2010 2015 20202000 time (years) (a) 16% case notif epidemiolog data 80% treatment success rate 85% treatment success rate 90% treatment success rate 95% treatment success rate 0 50 100 150 200 250 300 350 400 pr ev al en ce /1 00 ,0 00 2005 2010 20152001 time (years) (b) 80% case notif figur 5: hypothesi 2: effect treatment popul good surveil poor surveillance. (a) figur depict rel increas effect treatment 80%, 85%, 90% 95% popul poor case detection, notif rate 16%. (b) figur show signific decreas preval increas effect treatment 80%, 85%, 90% 95%, popul good case detection, notif rate 80%. epidemiolog data 16% notif 20% notif 25% notif 30% notif 0 50 100 150 200 250 300 350 400 pr ev al en ce /1 00 ,0 00 2010 2020 2030 2040 2050 20602000 time (years) (a) epidemiolog data 16% notif 30% notif 60% notif 85% notif 0 50 100 150 200 250 300 350 400 pr ev al en ce /1 00 ,0 00 2010 2020 2030 2040 2050 20602000 time (years) (b) figur 6:hypothesi 1: effect strategi gradual increas tuberculosi notif case poor tuberculosi surveillance. (a) result predict model notif new tuberculosi case gradual increased. red curv show poor notif rate situation, repres present situat tuberculosi nigeria (the blue stars). rest curv repres chang case detect increas notif new case percentag period time. (b) result predict notif new tuberculosi case suddenli increased. incid tb, complet clear connect influenc dynam diseas population. hypothesi impli poor case detect lead higher number unnotifi tb cases, lead high number latent infect individu risk develop activ tb, result persist high tb prevalence. model virtual experiment devic test effect latent infect popul nigeria, provid signific inform difficult imposs guess otherwise. go preval tb nigeria substanti high nondecreas long period time. explor effect increas notif rate treatment success ltbi popul (figur 7). figur 7(a) show result simul latent infect popul carri differ notif parameters. latent infect popul consist declin increas notif rate. result explain popul poor case detect program fail achiev signific progress reduc new tb cases, latent infect popul remain long period time call replac principle, sick tb patient produc sick patient death progress receiv treatment (the number new case complex 9 ltbi: baselin ltbi: 30% notif ltbi: 60% notif ltbi: 85% notif 1 1.5 2 2.5 3 3.5 4 4.5 la te nt ly fe ct ed /1 00 ,0 00 2005 2010 2015 20202000 time (years) 10 4 (a) ltbi: baselin ltbi: 85% effect treatment ltbi: 90% effect treatment ltbi: 95% effect treatment 1.5 2 2.5 3 3.5 4 4.5 la te nt ly fe ct ed /1 00 ,0 00 2005 2010 2015 20202000 time (years) 10 4 (b) figur 7: hypothesi 3: chang latent tuberculosi respect increas notif rate effect treatment. (a) simul dynam latent infect popul (ltbi) differ notif levels, paramet kept constant popul nigeria. red curv show ltbi popul remain constant 20 years, produc new sick peopl constantly. increas notif 30%, pool ltbi start decreas (blue curve), increas notif show higher decreas pool ltbi (black curve, 85% notif rate). (b) simul ltbi popul improv effect treatment, paramet kept constant popul nigeria. littl chang number ltbi case increas effect treatment. receiv treatment low). type situat guarante consist product newer tb case activ case find implemented. increas notif rate affect activ new tb case latent infect population. 10% increas notif associ 38% declin latent infectedtb (figur 7(a) 8), 10% increas effect treatment show 2.9% declin latent infect popul (figur 7(b)). 3.3. hypothesi 4: poor notif mortal sick pop- ulation. wefin test hypothesi low notif rate result massiv death sick population. phenomenon mysteri nigeria death report authorities. death occur notifi case tb record death disease. notif rate tb nigeria 16%, wonder death case tb went unnoticed. mention earlier, notif 16% fit data model. figur 9 show estim tb-relat mortal thousand individu popul nigeria obtain model. present-dai mortal rate nigeria shown red curve, show mortal tb nigeria 70 65 individu 100,000 individuals. result consist report [35]. model show increas notif 10% lead decreas mortal 20%. actually, figur 9 notif increas 16% 25%, mortal declin 60/100,000 individuals, impli hundr thousand live saved. latent infect popul 10 year 20 30 40 50 60 70 80 9010 notif rate (%) 1.5 2 2.5 3 3.5 4 4.5 la te nt ly fe ct ed /1 00 ,0 00 10 4 figur 8: hypothesi 3: latent infect popul 10 year simul model differ notif levels. point curv repres correspond popul latent infect compartments, model simul correspond notif rate x-axis. order better understand dynamics, estim mortal rate nigeria 10 year simul model differ notif parameters, start current situat nigeria (notif rate 16%). result experi shown figur 10. expect cumul number death tb 16% notif 10 year simul 10 complex 2000 2002 2004 2006 2008 2010 time (years) 16% notif 20% notif 25% notif 30% notif 60% notif 85% notif 0 10 20 30 40 50 60 70 m ta lit y/ 10 0, 00 0 figur 9: hypothesi 4: figur show decreas mortal tuberculosi sick popul period 10 year differ notif levels. red curv repres current mortal tuberculosi nigeria (baseline), rest curv situat look like notif different. 4,748,971. increas notif rate 20% save 292,244 live period. notif rate increas 25%, 584,489 live save period. estim tb preval nigeria 1990 year 2016 remain same, estim number new case increas annually. attribut increas popul country, but, time, show massiv increas number death tb popul estim model. estim new tb case rise 310,000 1990 600,000 2015, estim number tb-relat death model rise 62,000 1990 120,000 2015. popul ofnigeria continu grow rate 3.2% annual [47] case find remain passiv 16% notification, tb-relat death reach 3,456,640 year 2030; twice current number death tb world report 2017 [3]. depend avail funds, polit willing implement activ case find nigeria, strategi implemented, million live save 2018 2030. globally, model predict total death number 11,872,530 individu 2017 2030. increas case detect 15% period save 2,557,160 live reduc incid 30%. 4. discuss epidemiolog data nigeria show tb situa- tion countri persist time, spite effort stakehold battl disease. mortal 10 20 30 40 50 60 70 d ea th /1 00 ,0 00 (a fte r 1 0 ye ar s) 20 30 40 50 60 70 80 9010 notif rate (%) figur 10:hypothesi 4: result 10-year simul themodel differ notif rates. point curv repres mortal sick popul model simul 10 year correspond notif rate x-axis. tb preval nigeria 1990wa 323/100,000 indi- viduals, todai number (330/100,000) accord who. situat observ number death diseas (70/100,000 todai compar 65/100,000 1990). reason steadi state tb epidem countri unclear. associ poverti popul growth. nigeria recent overtook india world poverti capit [48] 87 million peopl abject poverti [48]. unpreced demograph growth (from 95,62 million peopl 1990 206,20 2018) mainli high fertil rate (5.526 accord world bank 2016). presum need better strategi order fight diseas signific declin near futur [11]. nigeria particular set healthcar option (medic pluralism) includ orthodox medicin (public, private, drugstores), tradit medicine, spiritu healer oper freeli [11].the public health facil tb control program oper distanc citizens. not, health facil choic health seek decisions. unlik theori dim dim [11] zwerl et al. [49], believ high tb preval nigeria lot polici tb control program, state studi [18, 45, 50, 51]. today, nigeria rank number 3 world term tb burden [52] china india. countri adopt passiv case find recommend [42], base studi conduct india [53, 54]. nevertheless, indian context complet differ demographic, cultural, literaci set fromnigeria.however, success tb control happen social cultur factor taken consider [55]. imper revis consid mean extend ntblcp strategy. complex 11 study, appli epidem model real pop- ulat draw conclus lead health challeng nigeria. numer show increas diagnosi rate treatment success tb patient essenti step tb control nigeria. order increas notif rate tb nigeria current passiv case detect strategy, peopl commun level empow adequ knowledg grow burden diseas access potenti cure. alternatively, activ case find strategi explor implemented, exist remot commun nigerian area dramat task difficult. case, analysi reveal that, current strategies, imposs actual aim endtb strategy, target reduc tb death 95% cut new tb case 90% 2015 2035 [56]. high increas notif with- consid hiv/tb coinfect problem multidrug-resist (mdr) strains, mortal tb nigeria dramat decad come. main fact contribut increas mortality: first, nigeria popul growth 3.2% annual [47, 57] and, second, result death tb expect drastic increas 2030 effect tb control implement country. result obtain studi confirm situation. issu pose great threat nigeria entir world tb program ambiti end tb partnership [56] 2030. increas tb diagnosi appli activ case find- ing specif action guarante tb treatment adher success achiev goal set nigeria reduc tb mortal significantly, tb prevalence, ltbi population. time come critic reexamin costs, risks, benefit activ case find country. indeed, strategi evalu paper requir substanti resourc extraordinari mobil intern attention, greater tb control program fund come extern sourc [42]. attempt estim cost differ control strategi proposed. initi sustain large- scale effort activ case find challenging. however, step need includ realist assess implement ambiti initi identif optim wai implement them. that, socioeconom context differ nigerian ter- ritori social inequ taken account, transform feasibl polici recommendations. furthermore, success guarante realist evalu cost pursu activ case find treatment new diagnos tb sick individuals. result explor differ scenario high relev increas notif rate contrast modest effect improv treatment efficaci only. nevertheless, treatment efficaci probabl turn crucial includ problem mdr, address studies. despit contempl absenc mdr limit model, conclus questioned, main problem pool nondiagnos tb sick individuals. futur studi includ studi reinfect effect model. new set allow detail studi ltbi popul distribut old recent infections. nonetheless, reinfect effect chang main dynam given current model recommend aros it. 5. conclus model show target state end tb strategi [56] achiev current public manag tb nigeria. fact, forecast situat 2030 suggest far awai end tb epidem aim unit nation sustain develop goal goal 3. high percentag undiagnos tb sick individu countri huge obstacl target incid disease. essenti increas number diagnos successfulli treated, requir signific econom effort boost social work community. result valid nigeria, countri nondiagnosi problem. cases, signifi- tb incid decreas achiev increas notif rate 80%-90% rang provid appropri manag diagnos patients. measures, new infect prevent treatment success guaranteed. situat bottleneck need overcom addit incorporation, improvement, and/or strengthen essenti tb control measur directli observ treatment contact tracing. data avail epidemiolog data support studi pre- viousli report studi datasets, cited. process data avail correspond author request. conflict author declar conflict interest. refer [1] t. paulson, mortal foe, nature, vol. 502, pp. s2s3, 2013. [2] r. m. houben, p. j. dodd, j. z. metcalfe, global burden latent tuberculosi infection: are-estimationus mathemat modelling, plo medicine, vol. 13, no. 10, p. e1002152, 2016. [3] worldhealth organization, global tuberculosi report, 2017. [4] p.-j. cardona, patogenesi la tuberculosi y otrasmicobacte- riosis, formacion medica continuada: infeccion por micobac- terias, vol. 36, no. 1, pp. 3846, 2018. 12 complex [5] k. bhatt p. salgame, host innat immun respons mycobacterium tuberculosis, journal clinic immunology, vol. 27, no. 4, pp. 347362, 2007. [6] p. peyron, j. vaubourgeix, y. poquet et al., foamymacrophag tubercul patient granuloma constitut nutrient- rich reservoir m. tuberculosi persistence, plo pathogens, vol. 4, no. 11, 2008. [7] r. l. hunter, patholog post primari tuberculosi lung: illustr critic review, tuberculosis, vol. 91, no. 6, pp. 497509, 2011. [8] w. w. stead, j. p. lofgren, e. warren, c. thomas, tuberculosi endem nosocomi infect elderli nurs homes, new england journal medicine, vol. 312, no. 23, pp. 14831487, 1985. [9] world health organ others, global tuberculosi report 2016, 2016. [10] a. aliyu l. amadu, urbanization, cities, health: challeng nigeria - review, annal african medicine, vol. 16, no. 4, pp. 149158, 2017. [11] c. dim n. dim, trend tuberculosi preval treatment outcom under-resourc setting: case enugu state, south east nigeria, nigerian medic journal, vol. 54, no. 6, p. 392, 2013. [12] punch, nigeria rank 4th tb infect worldwid report, tion-rate-worldwide-report/. [13] nigeria develop data, dividend.org/countri highlights/nigeria/. [14] r. yaesoubi t. cohen, identifi dynam tuberculosi case-find polici hiv/tb coepidemics, proceed nation acadamyof scienc unit state america, vol. 110, no. 23, pp. 94579462, 2013. [15] j. v. lazarus, m. olsen, l. ditiu, s. matic, tuberculosis- hiv co-infection: polici epidemiolog 25 countri european region, hiv medicine, vol. 9, no. 6, pp. 406414, 2008. [16] d. okuongha b. o. ikhimwin, dynam mathe- matic model tuberculosi variabl suscept diseas progress differ awar level, frontier microbiology, vol. 6, 2016. [17] t. f. brewer, g. a. colditz, s.m.krumplitsch, s. j. heymann,m. e.wilson, andh.v. fineberg, strategi decreas tuberculo- si homeless populations: simul model, journal american medic association, vol. 286, no. 7, pp. 834842, 2001. [18] p. j. dodd, r. g. white, e. l. corbett, s. p. tripathy, period activ case find tb: look? plo one, vol. 6, no. 12, p. e29130, 2011. [19] p. kim c. h. lee, epidem spread complex net- work resili nodes: applic fmd,complexity, vol. 2018, articl id 5024327, 9 pages, 2018. [20] a. corberan-vallet, f. j. santonja, m. jornet-sanz, r.-j. villanueva, model chickenpox dynam discret time bayesian stochast compartment model, complexity, vol. 2018, articl id 3060368, 9 pages, 2018. [21] s. i. bala n. m. ahmad, bistabl analysi mathe- matic model m-phase control xenopu oocyt extracts, comput appli mathematics, vol. 37, no. 3, pp. 26672692, 2018. [22] c. ozcaglar, a. shabbeer, s. l. vandenberg, b. yener, k. p. bennett, epidemiolog model mycobacterium tuberculosi complex infections,mathemat biosciences, vol. 236, no. 2, pp. 7796, 2012. [23] m. r. nyendak, b. park, m. d. null et al., mycobacterium tuberculosi specif cd8+ t cell rapidli declin anti- tuberculosi treatment, plo one, vol. 8, no. 12, p. e81564, 2013. [24] h. j. na, j. s. eom, g. lee et al., exposur mycobacterium tuberculosi flexibl bronchoscopi patient unexpect pulmonari tuberculosis, plo one, vol. 11, no. 5, 2016. [25] l. telisinghe, k. l. fielding, j. l. malden et al., high tubercu- losi preval south african prison:th need routin tuberculosi screening, plo one, vol. 9, no. 1, articl id e87262, 2014. [26] p. nahid, e. e. bliven, e. y. kim et al., influenc m. tuber- culosi lineag variabl clinic trial pulmonari tuberculosis, plo one, vol. 5, no. 5, 2010. [27] a. parhar, z. gao, c. heffernan, r. ahmed, m. l. egedahl, r. long, earli tuberculosi death associ increas tuberculosi transmission? plo one, vol. 10, no. 1, 2015. [28] j.-m. garca-garca, r. blanquer, t. rodrigo et al., social, clinic andmicrobiolog differenti characteristicsof tuber- culosi immigr spain, plo one, vol. 6, no. 1, 2011. [29] j. millet, a. orcau, c. riu et al., predictor death patient complet tuberculosi treatment: population-bas cohort study, plo one, vol. 6, no. 9, p. e25315, 2011. [30] shaip krasniqi, arianit jakupi, armond daci et al., tubercu- losi treatment adher patient kosovo, tuberculosi research treatment, vol. 2017, articl id 4850324, 8 pages, 2017. [31] s.w.asgedom,m. teweldemedhin, andh.gebreyesus, preva- lenc multidrug-resist tuberculosi associ fac- tor ethiopia: systemat review, journal pathogens, vol. 2018, articl id 7104921, 8 pages, 2018. [32] l. liu y. wang, mathemat studi tb model treatment interrupt latent periods,comput mathemat method medicine, vol. 2014, articl id 932186, 15 pages, 2014. [33] s. liu, a. li, x. feng, x. zhang, k. wang, dynam model human livestock tuberculosi spread control inurumqi, xinjiang, china,comput andmath- emat method medicine, vol. 2016, 2016. [34] f. a. krsulovic, m. lima, p. cardona, tuberculosi epidemiolog countri scale: self-limit process hiv effects, plo one, vol. 11, no. 4, p. e0153710, 2016. [35] world health organization, media centre: tuberculosis, fact sheet, 2016. [36] r. s. wallis, mathemat model tuberculosi reactiva- tion relapse, frontier microbiology, vol. 7, 2016. [37] d. p. moualeu-ngangue, s. roblitz, r. ehrig, p. deufl- hard, paramet identif tuberculosi model cameroon, plo one, vol. 10, no. 4, 2015. [38] s. ohno,evolut gene duplication, springer berlinheidel- berg, 1970. [39] b. song, c. castillo-chavez, j. p. aparicio, tuberculosi model fast slow dynamics: role close casual contacts, mathemat biosciences, vol. 180, no. 1-2, pp. 187 205, 2002. complex 13 [40] g. guzzetta, m. ajelli, z. yang, s. merler, c. furlanello, d. kirschner, model socio-demographi captur tuberculosi transmiss dynam low burden setting, journal theoret biology, vol. 289, no. 1, pp. 197205, 2011. [41] b. m. murphy, b. h. singer, d. kirschner, treatment tuberculosi heterogen populations, journal theoret- ical biology, vol. 223, no. 4, pp. 391404, 2003. [42] nigeria tuberculosi fact sheet, unit state embassi nigeria, 2012. [43] a. zumla, a.george, v. sharma, r.h.n.herbert, a.oxley, m. oliver, thewho 2014 global tuberculosi reportfurth go,th lancet global health, vol. 3, no. 1, pp. e10e12, 2015. [44] h.h.kyu, e. r.maddison,n. j. henri et al., global burden tuberculosis: result theglob burden diseas studi 2015, lancet infecti diseases, vol. 18, pp. 261284, 2018. [45] c. lienhardt, p. glaziou, m. uplekar, k. lonnroth, h. getahun, andm. raviglione, global tuberculosi control: lesson learnt futur prospects, natur review microbiology, vol. 10, no. 6, pp. 407416, 2012. [46] center diseas control prevent (us) andnat center prevent servic (us). divis tuberculosi elimin andnat center hiv std tb pre- vention (us). divis tuberculosi elimination, report tuberculosi unit states; depart health human services, public health service, center diseas control prevention, nation center prevent ser- vices, divis tuberculosi elimination, 1999. [47] usaid, health fact sheet, default/files/documents//usaid-nigeria-health-fact-sheet .pdf. [48] vanguard new paper, nigeria overtak india world poverti capit report, nigeria-overtakes-india-as-worlds-poverty-capital-report/ vanguard new paper. [49] a. zwerling, s. shrestha, d. w. dowdy, mathemat model tuberculosis: advanc diagnost novel therapies, advanc medicine, vol. 2015, articl id 907267, 10 pages, 2015. [50] n. a. menzies, t. cohen, h.-h. lin, m. murray, j. a. salomon, popul health impact cost-effect tuberculosi diagnosi xpert mtb/rif: dynam simul econom evaluation, plosmedicine, vol. 9, no. 11, articl id e1001347, 2012. [51] c. j. l. murrai j. a. salomon, model impact global tuberculosi control strategies, proceed nation acadami scienc unit state america, vol. 95, no. 23, pp. 1388113886, 1998. [52] nigeria tuberculosi profile, data/profiles/en/profile. [53] d. r. nagpaul, m. k. vishwanath, g. dwarakanath, socio-epidemiolog studi out-pati attend citi tuberculosi clinic india judg place special centr tuberculosi control programme., bulletin world health organization, vol. 43, no. 1, pp. 1734, 1970. [54] d. banerji s. andersen, sociolog studi awar symptom person pulmonari tuberculosis, bulletin world health organization, vol. 29, pp. 665683, 1963. [55] a. j. rubel l. c. garro, social cultur factor success control tuberculosis, public health reports, vol. 107, no. 6, pp. 626635, 1992. [56] worldhealthorganization, theendtb strategy, .who.int/tb/end tb brochure.pdfstrategy. [57] m. w. rosegrant, m. c. agcaoili-sombilla, n. d. perez, global food project 2020: implic investment, dian publishing, 1995. new paper new paper new paper hindawi www.hindawi.com volum 2018 mathemat journal hindawi www.hindawi.com volum 2018 mathemat problem engin appli mathemat journal hindawi www.hindawi.com volum 2018 probabl statist hindawi www.hindawi.com volum 2018 journal hindawi www.hindawi.com volum 2018 mathemat physic advanc complex analysi journal hindawi www.hindawi.com volum 2018 optim journal hindawi www.hindawi.com volum 2018 hindawi www.hindawi.com volum 2018 engin mathemat intern journal hindawi www.hindawi.com volum 2018 oper research advanc journal hindawi www.hindawi.com volum 2018 function space abstract appli analysi hindawi www.hindawi.com volum 2018 intern journal mathemat mathemat scienc hindawi www.hindawi.com volum 2018 hindawi publish corpor volum 2013 hindawi www.hindawi.com scientif world journal volum 2018 hindawi www.hindawi.com volum 2018volum 2018 numer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysi advanc inadv discret dynam natur societi hindawi www.hindawi.com volum 2018 hindawi www.hindawi.com dierenti equat intern journal volum 2018 hindawi www.hindawi.com volum 2018 decis scienc advanc hindawi www.hindawi.com volum 2018 analysi intern journal hindawi www.hindawi.com volum 2018 stochast analysi intern journal submit manuscript www.hindawi.com